Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma ; volume:9 ; number:1 ; day:15 ; month:7 ; year:2024 ; pages:1-23 ; date:12.2024
EJNMMI radiopharmacy and chemistry ; 9, Heft 1 (15.7.2024), 1-23, 12.2024
- Creator
-
Waked, Anthony
Crabbé, Melissa
Neirinckx, Virginie
Pérez, Sunay Rodriguez
Wellens, Jasmien
Rogister, Bernard
Benotmane, M. Abderrafi
Vermeulen, Koen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41181-024-00282-y
- URN
-
urn:nbn:de:101:1-2410012106195.750046471664
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Waked, Anthony
- Crabbé, Melissa
- Neirinckx, Virginie
- Pérez, Sunay Rodriguez
- Wellens, Jasmien
- Rogister, Bernard
- Benotmane, M. Abderrafi
- Vermeulen, Koen
- SpringerLink (Online service)
Other Objects (12)
Struktur-Aktivitätsbeziehung eines CXCR4-mimetischen Peptides
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
Radionuclide
Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma
Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies
Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy
Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities
Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme
Struktur-Aktivitätsbeziehung eines CXCR4-mimetischen Peptides
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
Radionuclide
Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma
Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies
Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy
Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities
Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme
Struktur-Aktivitätsbeziehung eines CXCR4-mimetischen Peptides
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
Radionuclide
Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma
Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies
Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy
Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities